Currently used Food and Drug Administration-approved transplant drugs with the addition of an also already FDA-approved complement inhibitor are the optimal immunosuppression regimen for pig-to-human kidney transplants, according to a landmark di
Currently used Food and Drug Administration-approved transplant drugs -; with the addition of an also already FDA-approved complement inhibitor -; are the optimal immunosuppression regimen for pig-to-human kidney transplants, according to a landmark discovery by University of Alabama at Birmingham investigators.
A court denied Sarunas restraining order request, citing insufficient evidence that great or irreparable harm would result, with a hearing slated to be held February 7.